Clinical Trials Browser

Phase 4 × niraparib × 90 days × Clear all

NCT06412120 2026-04-23

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

Phase 4 Recruiting

Ovarian Neoplasms